Interestingly, these KI mice also manifested increased GI tumor development in the DSS/azoxymethane tumor model suggesting that increased LRRK2 levels and kinase activity may unleash both increased gut inflammation and tumorigenesis. Here, LRRK2 is linked to digestive system neoplasm.